ZimVie Inc. (NASDAQ:ZIMV - Get Free Report) dropped 1.4% during trading on Wednesday . The company traded as low as $8.34 and last traded at $8.72. Approximately 218,065 shares changed hands during trading, an increase of 17% from the average daily volume of 187,174 shares. The stock had previously closed at $8.84.
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on ZIMV shares. B. Riley started coverage on shares of ZimVie in a research report on Thursday, April 10th. They set a "buy" rating and a $16.00 price objective on the stock. Needham & Company LLC reiterated a "hold" rating on shares of ZimVie in a research report on Wednesday, April 9th. UBS Group reduced their price objective on shares of ZimVie from $16.00 to $10.00 and set a "neutral" rating on the stock in a research report on Thursday, May 15th. Finally, Wall Street Zen cut shares of ZimVie from a "strong-buy" rating to a "buy" rating in a research report on Friday.
Read Our Latest Stock Analysis on ZimVie
ZimVie Trading Down 2.5%
The stock's 50 day moving average is $9.05 and its two-hundred day moving average is $10.92. The company has a market capitalization of $235.03 million, a PE ratio of -11.89 and a beta of 2.07. The company has a quick ratio of 1.48, a current ratio of 2.14 and a debt-to-equity ratio of 0.58.
ZimVie (NASDAQ:ZIMV - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.27 EPS for the quarter, topping analysts' consensus estimates of $0.21 by $0.06. The business had revenue of $112.00 million during the quarter, compared to the consensus estimate of $113.10 million. ZimVie had a negative net margin of 4.40% and a positive return on equity of 5.53%. As a group, sell-side analysts predict that ZimVie Inc. will post 0.6 EPS for the current fiscal year.
Institutional Investors Weigh In On ZimVie
A number of hedge funds and other institutional investors have recently made changes to their positions in ZIMV. Bank of New York Mellon Corp lifted its holdings in ZimVie by 0.9% in the 4th quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company's stock valued at $1,404,000 after purchasing an additional 943 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in ZimVie by 18.7% in the 4th quarter. JPMorgan Chase & Co. now owns 217,773 shares of the company's stock valued at $3,038,000 after purchasing an additional 34,354 shares in the last quarter. LPL Financial LLC purchased a new position in ZimVie in the 4th quarter valued at $993,000. BNP Paribas Financial Markets purchased a new position in ZimVie in the 4th quarter valued at $416,000. Finally, Fox Run Management L.L.C. purchased a new position in ZimVie in the 4th quarter valued at $463,000. Institutional investors and hedge funds own 95.63% of the company's stock.
About ZimVie
(
Get Free Report)
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Further Reading
Before you consider ZimVie, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZimVie wasn't on the list.
While ZimVie currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
